DaVita officials expound on potential acquistions with cash windfall

Favicon Denver Business Journal

Flush with $4.9 billion in cash from the pending sale of its medical group and as much as $130 million in expected benefits from federal tax reform, DaVita Inc. (NYSE: DVA) CEO Kent Thiry said Tuesday that the company will look to repurchase shares, grow its kidney-care business and make “a limited number of investments” in other health-care companies. The comments came during a quarterly earnings call — the Denver-based kidney-care provider’s first since it announced the sale of its disappointing...

Read the full article here: Denver Business Journal

The post: «DaVita officials expound on potential acquistions with cash windfall» has been published on the website Denver Business Journal where, everyday, you can find the latest news about Denver's area.

Get more articles about this topic

Leave a comment